| Literature DB >> 18019844 |
Jim Moselhy1, Swapna Sarkar, Maria C Chia, Joseph D Mocanu, Nicolas Taulier, Fei-Fei Liu, Xiao Yu Wu.
Abstract
Entities:
Mesh:
Substances:
Year: 2007 PMID: 18019844 PMCID: PMC2676666
Source DB: PubMed Journal: Int J Nanomedicine ISSN: 1176-9114
Properties of NIPAM/DMAEM copolymers
| ND0/100LMW | 0 | 0 | 1.73 | 7.5 |
| ND0/100HMW | 0 | 0 | 289 | 7.0 |
| ND15/85LMW | 10.9 | 15.0 | 3.26 | 7.5 |
| ND15/85HMW | 13.1 | 15.0 | 197 | 7.0 |
| ND30/70LMW | 22.8 | 30.0 | 2.82 | 7.5 |
| ND30/70HMW | 25.8 | 30.0 | 193 | 7.0 |
| ND50/50LMW | 52.0 | 50.0 | 1.89 | 7.6 |
| ND50/50HMW | 56.6 | 50.0 | 87.4 | 7.1 |
Copolymer nomenclature: N – NIPAM, D – DMAEM, %mol NIPAM/%mol DMAEM in polymerization feed, LMW – low molecular weight, HMW – high molecular weight.
LMW samples incorporate 10% mol 2-mercaptoethanol relative to total monomer content in polymerization feed.
Figure 1Intensity-averaged hydrodynamic diameter of low molecular weight (A), and high molecular weight (B) NIPAM/DMAEM PECs at different degrees of charge neutralization of pDNA (n = 3).
Figure 2Zeta potential of low molecular weight (A) and high molecular weight (B) NIPAM/DMAEM PECs at different degrees of charge neutralization of pDNA (n = 3).
Properties of NIPAM/DMAEM PECs.
| PEI | 115 ± 26 | 25.3 ± 1.0 | 2.5 | 0.5 |
| ND0/100LMW | 131 ± 30 | 14.7 ± 0.8 | 3.9 | 0.6 |
| ND0/100HMW | 133 ± 36 | 20.6 ± 0.8 | 3.0 | 0.6 |
| ND15/85LMW | 140 ± 30 | 13.6 ± 1.2 | 5.6 | 0.8 |
| ND15/85HMW | 125 ± 17 | 16.9 ± 1.5 | 3.5 | 0.9 |
| ND30/70LMW | 140 ± 20 | 9.2 ± 0.5 | 7.4 | 1.7 |
| ND30/70HMW | 123 ± 18 | 12.2 ± 0.8 | 5.5 | 1.6 |
| ND50/50LMW | 187 ± 30 | 5.9 ± 1.1 | 9.6 | 4.0 |
| ND50/50HMW | 146 ± 23 | 8.8 ± 0.9 | 7.3 | 4.2 |
The diameter, DI, min, and the zeta-potential are presented as mean ±SD (n = 3).
Figure 3Inhibition of ethidium bromide intercalation complexes with pDNA by low molecular weight (A) and high molecular weight (B) NIPAM/DMAEM copolymers (n = 3).
Figure 4Agarose gel retardation assay of PECs. Lane 1, DNA ladder; lane 2 pDNA; PECs prepared with, lanes 3–5, PEI (N:P); lanes 6–8, PLL, lanes 9–12, ND0/100HMW.
Figure 5Agarose gel retardation assay of LMW NIPAM/DMAEM PECs. Lane 1, DNA ladder; lane 2 pDNA; PECs prepared with, lanes 3–5, ND0/100LMW; lanes 6–8, ND15/85LMW, lanes 9–12, ND30/70LMW.
Figure 6CD spectra of pDNA and ND0/100HMW PECs (N:P = 5:1).
Figure 7Temperature and N:P ratio dependence of CD spectra of ND50/50HMW PECs.
Figure 8CD Spectra of Ad5; Type I Ad5-ND0/100HMW (1000 molecules/particle); Type II Ad5 coupled with ND0/100HMW:pDNA N:P =10:1; PEC (ND0/100HMW: pDNA N:P =10:1); pDNA.
Figure 9Transmission electron micrographs of adenovirus (top left), ND0/100HMW polymer-modified adenovirus at high and low resolution (top right and bottom plates, respectively).
Figure 10Toxicity of NIPAM/DMAEM copolymers towards CNE-1 nasopharyngeal carcinoma cells; A) ND0/100; B) ND15/85; C) ND30/70; D) ND50/50 (n = 3).
Figure 11Luciferase expression in C666-1 nasopharyngeal carcinoma cells of NIPAM/DMAEM PECs. Grey shaded samples represent high molecular weight NIPAM/ DMAEM PECs; white bars represent low molecular weight NIPAM/DMAEM PECs. Black filled samples are the negative (pDNA) and positive controls, PEI and Ad5 oriP/Luc. For PECs N:P = 10 Ad5 MOI = 50, (n = 3).
Figure 12Luciferase expression in CNE-1 transfected with Type I Ad5-CMV/luc. Numbers in parentheses denote (MOI/ng polymer) in Ad5 suspension (n = 3).
Figure 13Luciferase expression in C666-1 transfected with Type II Ad5-CMV/Luc complexes at MOI = 10 pfu, N:P ratio of PEC in parentheses. + denotes active expression via plasmid or adenovirus, –denotes UV knockout; the first sign refers to plasmid, the second to Ad5 (n = 3).